OPC-31260

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1416
Ligand NameOPC-31260
PubMed Compound Id119369
StructureProduct Image
Molecular FormulaC27H29N3O2
Molecular Weight427.5
SMILESCC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)N3CCCC(C4=CC=CC=C43)N(C)C
SynonymsMozavaptan
Mozavaptan [INN]
Opc 31260
Mozavaptane
OPC31260
DTXSID8057641
UNII-17OJ42922Y
MOZAVAPTAN [MI]
17OJ42922Y
MOZAVAPTAN [MART.]
MOZAVAPTAN [WHO-DD]
5-Dimethylamino-1-(4-(2-methylbenzoylamino)benzoyl)-2,3,4,5-tetrahydro-1H-benzazepine
N-(4-(((5RS)-5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide
DTXCID9031430
Benzamide, N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-
N-(4-((5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide
MOZAVAPTAN (MART.)
Benzamide, N-(4-((5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methyl-
N-[4-(5-dimethylamino2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-2-methylbenzamide
mozavaptanum
N-(4-(5-dimethylamino2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl)-2-methylbenzamide
137975-06-5
Opc-31260
N-(4-(5-(dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide
Mozavaptan free base
N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide
CHEMBL420762
137975-06-5 (free base)
C27H29N3O2
N-[4-[[5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methylbenzamide; OPC 31260;
MFCD00908918
GTPL2197
SCHEMBL1649322
BDBM35714
CHEBI:135694
GLXC-05184
BCP06718
EX-A1127
Tox21_113926
s2920
AKOS015895761
AC-4255
CCG-268974
CS-6286
FD71413
SB18801
NCGC00262931-01
NCGC00262931-02
AS-35085
HY-18346
CAS-137975-06-5
NS00126434
L001435
BRD-A31095847-001-02-3
Q12746116
N-[4-(5-Dimethylamino-2,3,4,5-tetrahydro-benzo[b]azepine-1-carbonyl)-phenyl]-2-methyl-benzamide
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm